TLR4 and congenital rubella syndrome: In summary, we demonstrated that PVP-I significantly attenuated inflammatory molecules and cytokines via blocking the formation of TLR4 and MyD88 complexes in the LPS-induced mucosal inflammation in non-eosinophilic CRS.